The delta opioid receptor subtypes and pain modulation

[1]  A. Beaudet,et al.  Immunohistochemical distribution of delta opioid receptors in the rat central nervous system: Evidence for somatodendritic labeling and antigen‐specific cellular compartmentalization , 2001, The Journal of comparative neurology.

[2]  C. Stiller,et al.  Morphine‐induced in vivo release of spinal cholecystokinin is mediated by δ‐opioid receptors – effect of peripheral axotomy , 2001, Journal of neurochemistry.

[3]  A. Dray,et al.  Spinal delta-opioid receptors mediate suppression of systemic SNC80 on excitability of the flexor reflex in normal and inflamed rat. , 2001, European journal of pharmacology.

[4]  R. Hurley,et al.  Contribution of Endogenous Enkephalins to the Enhanced Analgesic Effects of Supraspinal μ Opioid Receptor Agonists after Inflammatory Injury , 2001, The Journal of Neuroscience.

[5]  Jisheng Han,et al.  The metabolic evidence of synergistic interaction between DAMGO and DPDPE on undifferentiated SH-SY5Y cells , 2001, Neuroreport.

[6]  R. Przewłocki,et al.  The role of δ-opioid receptor subtypes in neuropathic pain , 2001 .

[7]  Jisheng Han,et al.  The metabolic evidence of synergistic effect between ohmefentanyl and [D-Pen2, D-Pen5] enkephalin on differentiated SH-SY5Y cells in humans , 2001, Neuroscience Letters.

[8]  C. Wahlestedt,et al.  Supraspinal Antinociceptive Response to [d-Pen2,5]-Enkephalin (DPDPE) Is Pharmacologically Distinct from That to Other δ-Agonists in the Rat , 2000 .

[9]  T. Hökfelt,et al.  Potent and nontoxic antisense oligonucleotides containing locked nucleic acids. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[10]  H. Fields,et al.  Delta opioid receptor mediated actions in the rostral ventromedial medulla on tail flick latency and nociceptive modulatory neurons , 2000, Pain.

[11]  G. Dondio.  Development of novel pain relief agents acting through the selective activation of the delta-opioid receptor. , 2000, Farmaco.

[12]  R. Hurley,et al.  The Analgesic Effects of Supraspinal μ and δ Opioid Receptor Agonists Are Potentiated during Persistent Inflammation , 2000, The Journal of Neuroscience.

[13]  M. Hamon,et al.  δ-Opioid receptor-mediated increase in cortical extracellular levels of cholecystokinin-like material by subchronic morphine in rats , 2000, Neuropharmacology.

[14]  K. Rice,et al.  Probes for narcotic receptor mediated phenomena. 26. Synthesis and biological evaluation of diarylmethylpiperazines and diarylmethylpiperidines as novel, nonpeptidic delta opioid receptor ligands. , 1999, Journal of medicinal chemistry.

[15]  V. Hruby,et al.  Lesions of the dorsolateral funiculus block supraspinal opioid delta receptor mediated antinociception in the rat , 1999, PAIN.

[16]  R. Hurley,et al.  Supraspinal and spinal delta 2 opioid receptor-mediated antinociceptive synergy is mediated by spinal alpha 2 adrenoceptors , 1999, PAIN.

[17]  M. Hamon,et al.  δ2‐opioid receptor mediation of morphine‐induced CCK release in the frontal cortex of the freely moving rat , 1999, Synapse.

[18]  E. Brodin,et al.  Pharmacological Characterization of Morphine‐Induced In Vivo Release of Cholecystokinin in Rat Dorsal Horn , 1999 .

[19]  Joshua F. Nitsche,et al.  Retention of Supraspinal Delta-like Analgesia and Loss of Morphine Tolerance in δ Opioid Receptor Knockout Mice , 1999, Neuron.

[20]  G. Schulte,et al.  Effects of sciatic nerve injuries on δ ‐opioid receptor and substance P immunoreactivities in the superficial dorsal horn of the rat , 1999, European journal of pain.

[21]  R. Tallarida,et al.  Interaction Between Medullary and Spinal δ1 and δ2 Opioid Receptors in the Production of Antinociception in the Rat , 1999 .

[22]  D. Peckys,et al.  Expression of mu, kappa, and delta opioid receptor messenger RNA in the human CNS: a 33P in situ hybridization study , 1999, Neuroscience.

[23]  A. Eschalier,et al.  Is the reduced efficacy of morphine in diabetic rats caused by alterations of opiate receptors or of morphine pharmacokinetics? , 1998, The Journal of pharmacology and experimental therapeutics.

[24]  A. Basbaum,et al.  Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat. , 1998, The Journal of pharmacology and experimental therapeutics.

[25]  D. Hammond,et al.  Modulation of nociception by microinjection of delta-1 and delta-2 opioid receptor ligands in the ventromedial medulla of the rat. , 1997, The Journal of pharmacology and experimental therapeutics.

[26]  T. Hökfelt,et al.  Localization and regulation of the delta-opioid receptor in dorsal root ganglia and spinal cord of the rat and monkey: evidence for association with the membrane of large dense-core vesicles , 1997, Neuroscience.

[27]  T. Milner,et al.  Localization of delta opioid receptor immunoreactivity in interneurons and pyramidal cells in the rat hippocampus , 1997 .

[28]  T. Vanderah,et al.  Differential activities of intrathecal MK-801 or morphine to alter responses to thermal and mechanical stimuli in normal or nerve-injured rats , 1997, Pain.

[29]  R. Lynch,et al.  Antisense targeting of delta opioid receptors in NG 108-15 cells: direct correlation between oligodeoxynucleotide uptake and receptor density. , 1997, The Journal of pharmacology and experimental therapeutics.

[30]  Robert Horvath,et al.  Probes for narcotic receptor mediated phenomena. 23.1 Synthesis, opioid receptor binding, and bioassay of the highly selective δ agonist (+)-4-[(αR)-α-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide (SNC 80) and related novel nonpeptide δ opioid receptor ligands , 1997 .

[31]  G. Catheline,et al.  The antinociceptive activity of κ- but not δ-opioid receptor agonists is maintained in morphine-tolerant neuropathic rats , 1996 .

[32]  C. M. Bertha,et al.  Rapid in vivo metabolism of a methylether derivative of (+/-)-BW373U86: the metabolic fate of [3H]SNC121 in rats. , 1996, The Journal of pharmacology and experimental therapeutics.

[33]  Xiao-jun Xu,et al.  The role of cholecystokinin in nociception, neuropathic pain and opiate tolerance , 1996, Regulatory Peptides.

[34]  J. Hunter,et al.  Opioid antagonists and antisera to endogenous opioids increase the nociceptive response to formalin: demonstration of an opioid kappa and delta inhibitory tone. , 1996, The Journal of pharmacology and experimental therapeutics.

[35]  Z. Wiesenfeld‐Hallin,et al.  L-740,093, a new antagonist of the CCK-B receptor, potentiates the antinociceptive effect of morphine: electrophysiological and behavioural studies , 1996, Neuropeptides.

[36]  A. Zimprich,et al.  Transfected rat µ opioid receptors (rMOR1 and rMOR1B) stimulate phospholipase C and Ca2+ mobilization , 1995, Neuroreport.

[37]  F. Porreca,et al.  Regulation of morphine antiallodynic efficacy by cholecystokinin in a model of neuropathic pain in rats. , 1995, The Journal of pharmacology and experimental therapeutics.

[38]  F. Porreca,et al.  Opioid antinociception in a rat model of visceral pain: systemic versus local drug administration. , 1995, The Journal of pharmacology and experimental therapeutics.

[39]  G. Pasternak,et al.  Antisense Oligodeoxynucleotides to the Cloned δ Receptor DOR‐1: Uptake, Stability, and Regulation of Gene Expression , 1995, Journal of neurochemistry.

[40]  F. Porreca,et al.  Characterization of the antiallodynic efficacy of morphine in a model of neuropathic pain in rats. , 1995, Neuroreport.

[41]  V. Hruby,et al.  Characterization of supraspinal antinociceptive actions of opiod delta agonists in the rat , 1995, Pain.

[42]  P. Stewart,et al.  Antinociception and delta-1 opioid receptors in the rat spinal cord: studies with intrathecal 7-benzylidenenaltrexone. , 1995, The Journal of pharmacology and experimental therapeutics.

[43]  C. Stevens,et al.  Changes of opioid binding density in the rat spinal cord following unilateral dorsal rhizotomy , 1995, Brain Research.

[44]  T. Coderre,et al.  mu-, delta- and kappa-opiate receptors mediate antinociception in the rat tail flick test following noxious thermal stimulation of one hindpaw. , 1995, The Journal of pharmacology and experimental therapeutics.

[45]  D. Price,et al.  Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain , 1995, Pain.

[46]  C. N. Honda,et al.  Immunohistochemical localization of delta‐ and mu‐opioid receptors in primate spinal cord , 1995, Neuroreport.

[47]  V. Hruby,et al.  SNC 80, a selective, nonpeptidic and systemically active opioid delta agonist. , 1995, The Journal of pharmacology and experimental therapeutics.

[48]  Lei Fang,et al.  Molecular biology and pharmacology of cloned opioid receptors 1 , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[49]  R. Knapp,et al.  Human δ opioid receptor: A stable cell line for functional studies of opioids , 1995 .

[50]  S. Appleyard,et al.  Immunocytochemical localization of delta opioid receptors in mouse brain , 1995, Journal of Chemical Neuroanatomy.

[51]  P. Law,et al.  delta-Opioid receptor immunoreactivity: distribution in brainstem and spinal cord, and relationship to biogenic amines and enkephalin , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[52]  Stanley J. Watson,et al.  Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications , 1995, Trends in Neurosciences.

[53]  F. Porreca,et al.  Treatment with antisense oligodeoxynucleotide to a conserved sequence of opioid receptors inhibits antinociceptive effects of delta subtype selective ligands. , 1995, Journal of receptor and signal transduction research.

[54]  H. Yamamura,et al.  Antisense oligodeoxynucleotide to the CCKB receptor produces naltrindole- and [Leu5]enkephalin antiserum-sensitive enhancement of morphine antinociception. , 1994, Neuroreport.

[55]  H. Akil,et al.  Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: An in situ hybridization study , 1994, The Journal of comparative neurology.

[56]  A. Ableitner.  Brain sites involved in δ-opioid receptor-mediated actions , 1994 .

[57]  G. Pasternak,et al.  μ and δ opioid synergy between the periaqueductal gray and the rostro-ventral medulla , 1994, Brain Research.

[58]  J. Flippen-Anderson,et al.  Probes for narcotic receptor mediated phenomena. 19. Synthesis of (+)-4-[(alpha R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3- methoxybenzyl]-N,N-diethylbenzamide (SNC 80): a highly selective, nonpeptide delta opioid receptor agonist. , 1994, Journal of medicinal chemistry.

[59]  M. Fournié-Zaluski,et al.  Cholecystokinin B antagonists strongly potentiate antinociception mediated by endogenous enkephalins. , 1994, The Journal of pharmacology and experimental therapeutics.

[60]  R. Rothman,et al.  Treatment with antisense oligodeoxynucleotide to the opioid δ receptor selectively inhibits δ2-agonist antinociception , 1994 .

[61]  G. Pasternak,et al.  Selective loss of δ opioid analgesia and binding by antisense oligodeoxynucleotides to a δ opioid receptor , 1994, Neuron.

[62]  Xiao-jun Xu,et al.  Cholecystokinin and morphine analgesia: variations on a theme. , 1994, Trends in pharmacological sciences.

[63]  T. Hökfelt,et al.  Chronic pain-related behaviors in spinally injured rats: Evidence for functional alterations of the endogenous cholecystokinin and opioid systems , 1994, Pain.

[64]  H. Mosberg,et al.  Interaction of [D-Pen2,D-Pen5]enkephalin and [D-Ala2,Glu4]deltorphin with delta-opioid receptor subtypes in vivo. , 1994, European journal of pharmacology.

[65]  R. Horváth,et al.  Characterization of [3H]naltrindole binding to delta opioid receptors in mouse brain and mouse vas deferens: evidence for delta opioid receptor heterogeneity. , 1994, The Journal of pharmacology and experimental therapeutics.

[66]  K. Befort,et al.  The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[67]  H. Mosberg,et al.  Convulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice. , 1993, The Journal of pharmacology and experimental therapeutics.

[68]  J. L. Howard,et al.  A novel, potent and selective nonpeptidic delta opioid receptor agonist BW373U86. , 1993, The Journal of pharmacology and experimental therapeutics.

[69]  T. Vanderah,et al.  Antinociceptive actions of BW373U86 in the mouse. , 1993, The Journal of pharmacology and experimental therapeutics.

[70]  C. Kozak,et al.  Regional expression and chromosomal localization of the delta opiate receptor gene. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[71]  R. Bodnar,et al.  Medullary μ and δ opioid receptors modulate mesencephalic morphine analgesia in rats , 1993, Brain Research.

[72]  W. Bowen,et al.  Modulation of morphine antinociception by swim-stress in the mouse: involvement of supraspinal opioid delta-2 receptors. , 1993, The Journal of pharmacology and experimental therapeutics.

[73]  R. Tallarida,et al.  Isobolographic superadditivity between delta and mu opioid agonists in the rat depends on the ratio of compounds, the mu agonist and the analgesic assay used. , 1993, The Journal of pharmacology and experimental therapeutics.

[74]  B. Roques,et al.  Modulation of opioid antinociception by CCK at the supraspinal level: evidence of regulatory mechanisms between CCK and enkephalin systems in the control of pain , 1993, British journal of pharmacology.

[75]  P. Stewart,et al.  Evidence for delta opioid receptor subtypes in rat spinal cord: studies with intrathecal naltriben, cyclic[D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4]deltorphin. , 1993, The Journal of pharmacology and experimental therapeutics.

[76]  B. Roques,et al.  Association of the peptidase inhibitor RB 101 and a CCK-B antagonist strongly enhances antinociceptive responses. , 1993, Neuroreport.

[77]  A. Herz,et al.  Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissue , 1993, Neuroscience.

[78]  J. Desmeules,et al.  Selective opioid receptor agonists modulate mechanical allodynia in an animal model of neuropathic pain , 1993, Pain.

[79]  S. Appleyard,et al.  Antinociceptive profile of biphalin, a dimeric enkephalin analog. , 1993, The Journal of pharmacology and experimental therapeutics.

[80]  E. Kalso,et al.  Cross-tolerance between mu opioid and alpha-2 adrenergic receptors, but not between mu and delta opioid receptors in the spinal cord of the rat. , 1993, The Journal of pharmacology and experimental therapeutics.

[81]  V. Hruby,et al.  Agonist and antagonist profiles of [D-Ala2,Glu4]deltorphin and its [Cys4]- and [Ser4]-substituted derivatives: further evidence of opioid delta receptor multiplicity. , 1993, The Journal of pharmacology and experimental therapeutics.

[82]  A. Dickenson,et al.  Cholecystokinin as a factor in the enhanced potency of spinal morphine following carrageenin inflammation , 1993, British journal of pharmacology.

[83]  V. Hruby,et al.  Unexpected antinociceptive potency of cyclic [D-Tca1]CTAP: potential for a novel mechanism of action. , 1993, European journal of pharmacology.

[84]  J. Zajac,et al.  Quantitative autoradiographic mapping of delta‐opioid receptors in the rat central nervous system using [125I][D.Ala2]deltorphin‐I , 1993, Synapse.

[85]  R. Edwards,et al.  Cloning of a delta opioid receptor by functional expression. , 1992, Science.

[86]  W. Maixner,et al.  Delta-opioid-receptor activation by [D-Pen2,D-Pen5]enkephalin and morphine inhibits substance P release from trigeminal nucleus slices. , 1992, European journal of pharmacology.

[87]  M. Broccardo,et al.  Spinal antinociceptive effects of [d-Ala2]deltorphin II, a novel and highly selective delta-opioid receptor agonist , 1992, Peptides.

[88]  M. Fournié-Zaluski,et al.  Stimulation of δ‐Opioid Receptors Reduces the In Vivo Binding of the Cholecystokinin (CCK)‐B‐Selective Agonist [3H]pBC 264: Evidence for a Physiological Regulation of CCKergic Systems by Endogenous Enkephalins , 1992, Journal of neurochemistry.

[89]  S. Perrot,et al.  Regulation of opioid binding sites in the superficial dorsal horn of the rat spinal cord following loose ligation of the sciatic nerve: Comparison with sciatic nerve section and lumbar dorsal rhizotomy , 1992, Neuroscience.

[90]  T. Yaksh,et al.  Isobolographic and dose-response analyses of the interaction between intrathecal mu and delta agonists: effects of naltrindole and its benzofuran analog (NTB). , 1992, The Journal of pharmacology and experimental therapeutics.

[91]  A. Dickenson,et al.  Alterations in neuronal excitability and the potency of spinal mu, delta and kappa opioids after carrageenan-induced inflammation , 1992, PAIN.

[92]  W. Bowen,et al.  Mediation of swim-stress antinociception by the opioid delta 2 receptor in the mouse. , 1992, The Journal of pharmacology and experimental therapeutics.

[93]  J. Levine,et al.  Antinociceptive and motor effects of delta/mu and kappa/mu combinations of intrathecal opioid agonists , 1992, Pain.

[94]  R. Dubner,et al.  Preproenkephalin mrna in spinal dorsal horn neurons is induced by peripheral inflammation and is co-localized with Fos and Fos-related proteins , 1992, Neuroscience.

[95]  W. Bowen,et al.  Spinal opioid delta antinociception in the mouse: mediation by a 5'-NTII-sensitive delta receptor subtype. , 1992, The Journal of pharmacology and experimental therapeutics.

[96]  F. Angelucci,et al.  Behavioural effects of deltorphins in rats. , 1991, European journal of pharmacology.

[97]  J. Levine,et al.  Contribution of supraspinal μ- and δ-opioid receptors to antinociception in the rat , 1991 .

[98]  B. de Costa,et al.  Selective antagonism by naltrindole of the antinociceptive effects of the delta opioid agonist cyclic[D-penicillamine2-D-penicillamine5]enkephalin in the rat. , 1991, The Journal of pharmacology and experimental therapeutics.

[99]  T. Yamamoto,et al.  Spinal pharmacology of thermal hyperesthesia induced by incomplete ligation of sciatic nerve. I. Opioid and nonopioid receptors. , 1991, Anesthesiology.

[100]  G. Bennett,et al.  Bilateral and differential changes in spinal mu, delta and kappa opioid binding in rats with a painful, unilateral neuropathy , 1991, Pain.

[101]  H. Mosberg,et al.  Lack of antinociceptive cross-tolerance between [D-Pen2, D-Pen5]enkephalin and [D-Ala2]deltorphin II in mice: evidence for delta receptor subtypes. , 1991, The Journal of pharmacology and experimental therapeutics.

[102]  G. Woodruff,et al.  Neurochemical actions of CCK underlying the therapeutic potential of CCK-B antagonists , 1991, Neuropeptides.

[103]  W. Bowen,et al.  Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5'-isothiocyanate: evidence for delta receptor subtypes. , 1991, The Journal of pharmacology and experimental therapeutics.

[104]  R. Elde,et al.  Biochemical characterization and regional quantification of μ, δ and κ opioid binding sites in rat spinal cord , 1991, Brain Research.

[105]  P. Portoghese,et al.  Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes. , 1991, The Journal of pharmacology and experimental therapeutics.

[106]  L. Negri,et al.  Evidence for two subtypes of δ opioid receptors in rat brain , 1991 .

[107]  Xiao-Jing Wang,et al.  Cholecystokinin octapeptide antagonized opioid analgesia mediated by μ- and κ- but not δ-receptors in the spinal cord of the rat , 1990, Brain Research.

[108]  P. Portoghese,et al.  Naltrindole 5'-isothiocyanate: a nonequilibrium, highly selective delta opioid receptor antagonist. , 1990, Journal of medicinal chemistry.

[109]  L. Tseng,et al.  Differential effects of sulfated cholecystokinin octapeptide and proglumide injected intrathecally on antinociception induced by beta-endorphin and morphine administered intracerebroventricularly in mice. , 1990, European journal of pharmacology.

[110]  R. Tallarida,et al.  Modulation of morphine antinociception by peripheral [Leu5]enkephalin: a synergistic interaction. , 1990, European journal of pharmacology.

[111]  S. Iversen,et al.  The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat. , 1990, European journal of pharmacology.

[112]  H. Mosberg,et al.  Modulation of ~-mediated antinociception by ~ agonists: characterization with antagonists , 1989 .

[113]  D. Barra,et al.  Deltorphins: a family of naturally occurring peptides with high affinity and selectivity for delta opioid binding sites. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[114]  J. Fujimoto,et al.  Multiplicative interaction between intrathecally and intracerebroventricularly administered mu opioid agonists but limited interactions between delta and kappa agonists for antinociception in mice. , 1989, The Journal of pharmacology and experimental therapeutics.

[115]  D. Barra,et al.  Deltorphin, a novel amphibian skin peptide with high selectivity and affinity for delta opioid receptors. , 1989, European journal of pharmacology.

[116]  S. Iversen,et al.  Morphine-induced analgesia in the rat paw pressure test is blocked by CCK and enhanced by the CCK antagonist MK-329 , 1989, Neuropharmacology.

[117]  B. Roques,et al.  Evidence that endogenous enkephalins and a delta opioid receptor agonist have a common site of action in spinal antinociception. , 1988, European journal of pharmacology.

[118]  B. Meyerson,et al.  Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain , 1988, Pain.

[119]  H. Mosberg,et al.  Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [d-Pen2, d-Pen5] enkephalin in the mouse F. Porreca, J.S. Heyman, H.I. Mosberg, J.R. Omnaas and J.L. Vaught, J. Pharmacol. Exp. Ther., 241 (1987) 393–400 , 1987, Pain.

[120]  W. Bowen,et al.  Affinity labeling of delta-opiate receptors using [D-Ala2,Leu5,Cys6]enkephalin. Covalent attachment via thiol-disulfide exchange. , 1987, The Journal of biological chemistry.

[121]  B. Roques,et al.  Use of μ and δ opioid peptides of various selectivity gives further evidence of specific involvement of μ opioid receptors in supraspinal analgesia (tail-flick test) , 1987 .

[122]  J. Besson,et al.  Opioid receptor types and antinociceptive activity in chronic inflammation: bothe κ- and μ-opiate agonistic effects are enhanced in arthritic rats , 1986 .

[123]  V. Hruby,et al.  Light microscopic autoradiographic localization of delta opioid receptors in the rat brain using a highly selective bis-penicillamine cyclic enkephalin analog. , 1986, The Journal of pharmacology and experimental therapeutics.

[124]  R. Payne.  Neuropathic Pain Syndromes, with Special Reference to Causalgia and Reflex Sympathetic Dystrophy , 1986 .

[125]  V. Hruby,et al.  Characterization of [3H][2-D-penicillamine, 5-D-penicillamine]-enkephalin binding to delta opiate receptors in the rat brain and neuroblastoma--glioma hybrid cell line (NG 108-15). , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[126]  L. Watkins,et al.  Potentiation of morphine analgesia by the cholecystokinin antagonist proglumide , 1985, Brain Research.

[127]  L. Watkins,et al.  Cholecystokinin antagonists selectively potentiate analgesia induced by endogenous opiates , 1985, Brain Research.

[128]  V. Hruby,et al.  Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse. , 1984, The Journal of pharmacology and experimental therapeutics.

[129]  T. Yaksh.  Multiple opioid receptor systems in brain and spinal cord: Part 2. , 1984, European journal of anaesthesiology.

[130]  V. Hruby,et al.  Cerebral delta opioid receptors mediate analgesia but not the intestinal motility effects of intracerebroventricularly administered opioids. , 1984, The Journal of pharmacology and experimental therapeutics.

[131]  T. Yaksh.  In vivo studies on spinal opiate receptor systems mediating antinociception. I. Mu and delta receptor profiles in the primate. , 1983, The Journal of pharmacology and experimental therapeutics.

[132]  P. Portoghese,et al.  Improved assays for the assessment of ϰ- and δ-properties of opioid ligands , 1982 .

[133]  A. Herz,et al.  Mixed type inhibition of [D-Ala2,D-Leu5]enkephalin binding to μ-opiate binding sites by μ-, but not by κ-opiate ligands , 1982 .

[134]  R. Schulz,et al.  Pharmacological characterization of the epsilon-opiate receptor. , 1981, The Journal of pharmacology and experimental therapeutics.

[135]  T. Rudy,et al.  Multiplicative interaction between narcotic agonisms expressed at spinal and supraspinal sites of antinociceptive action as revealed by concurrent intrathecal and intracerebroventricular injections of morphine. , 1980, The Journal of pharmacology and experimental therapeutics.

[136]  A. Takemori,et al.  A further characterization of the differential effects of leucine enkephalin, methionine enkephalin and their analogs on morphine-induced analgesia. , 1979, The Journal of pharmacology and experimental therapeutics.

[137]  N. Ling,et al.  Opioid activities of fragments of beta-endorphin and of its leucine65-analogue. Comparison of the binding properties of methionine- and leucine-enkephalin. , 1979, European journal of pharmacology.

[138]  John Hughes,et al.  Endogenous opioid peptides: multiple agonists and receptors , 1977, Nature.

[139]  J. Thompson,et al.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. , 1976, The Journal of pharmacology and experimental therapeutics.

[140]  R. Sofia,et al.  Anti-edema and analgesic properties of delta9-tetrahydrocannabinol (THC). , 1973, The Journal of pharmacology and experimental therapeutics.

[141]  E. J. Simon.  In search of the opiate receptor. , 1973, The American journal of the medical sciences.

[142]  S. Snyder,et al.  Properties of opiate-receptor binding in rat brain. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[143]  S. Snyder,et al.  Opiate Receptor: Demonstration in Nervous Tissue , 1973, Science.